Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression
The Journal of Immunology · 09.02.2026 · 215 (2)
DOI: 10.1093/jimmun/vkaf365 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 01.03.2026. Verfasst von Sriganesh B Sharma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, University of Michigan, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, COVID-19, SARS-CoV-2, Macrophages. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Lefkofsky Family Foundation, NHLBI NIH HHS, National Institutes of Health National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Urokinase (uPA) and urokinase plasminogen activator receptor (uPAR/PLAUR) mediate fibrinolysis and matrix remodeling. Liberation of monocyte/macrophage (MO/Mφ)-bound soluble uPAR (suPAR) occurs after infection with coronaviruses (CoVs) such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), correlating with systemic inflammatory stress and end-organ injury severity. How suPAR liberation from MO/Mφs occurs after CoV infection, and whether suPAR induction is exclusive to coronavirus infection or occurs from other clinically significant coagulopathy-inducing pneumotropic viral infections such as influenza A (IAV), is unknown. We noted increased PLAUR transcripts in peripheral blood mononuclear cells (PBMCs) from SARS-CoV-2-positive and IAV-positive patients. Elevated suPAR liberation was observed after murine CoV infection but not IAV infection—both of which led to increased MO/Mφ mRNA and cell-bound uPA and uPAR, and increased secreted uPA activity. uPA knockdown in MO/Mφs abrogated suPAR liberation and blunted tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 induction post-CoV, suggesting that targeting co-regulators of uPAR and uPA may be beneficial in attenuating coronavirus-driven inflammatory cytokine responses, and treating diseases characterized by suPAR release from Mφs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, University of Michigan, Ann Arbor, MI, United States.
- Section of Vascular Surgery, University of Michigan, Ann Arbor, MI, United States.
- Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States.
- University of Michigan School of Medicine, Ann Arbor, MI, United States.
- Bioinformatics Core, Biomedical Research Core Facilities, University of Michigan, Ann Arbor, MI, United States.
- Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.
ORCID-Profile: Kiran Kumar
Förderung
- Lefkofsky Family Foundation
- NHLBI NIH HHS
- National Institutes of Health National Heart, Lung, and Blood Institute
- Elizabeth Anne Baiardi Research Fund
- Vascular Cures Foundation
- University of Michigan Cardiovascular Center COVID
Zitieren
APA
Sharma, S. B., Kumar, K., Parchment, N., Eggleston, T., De Melo Jorge, D. M., Bamezai, S., Wu, W., Moore, B. B., Hayek, S. S., Hogan, S. P., Henke, P. K., Gallagher, K. A., & Obi, A. T. (2026). Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression. The Journal of Immunology, 215(2). https://doi.org/10.1093/jimmun/vkaf365
Vancouver
Sharma SB, Kumar K, Parchment N, Eggleston T, De Melo Jorge DM, Bamezai S, et al. Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression. The Journal of Immunology. 2026;215(2). doi:10.1093/jimmun/vkaf365
BibTeX
@article{Sharma2026,
author = {Sharma, Sriganesh B and Kumar, Kiran and Parchment, Nathaniel and Eggleston, Trevin and De Melo Jorge, Daniel Macedo and Bamezai, Sharika and Wu, Weisheng and Moore, Bethany B and Hayek, Salim S and Hogan, Simon P and Henke, Peter K and Gallagher, Katherine A and Obi, Andrea T},
title = {Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {2},
doi = {10.1093/jimmun/vkaf365}
}
EUVIMED